Duchesnay Flagged for Omitting Risks of Morning Sickness Drug

$25.00
Shortly after Duchesnay received FDA approval for its morning sickness drug Diclegis, the agency says the Canadian drugmaker sent a letter to customers touting the drug’s benefits but none of its risks.